ProfileGDS4718 / 243957_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 39% 56% 43% 38% 40% 37% 41% 38% 39% 39% 42% 34% 35% 35% 43% 39% 39% 39% 32% 38% 38% 39% 40% 41% 38% 40% 39% 41% 36% 36% 35% 43% 42% 37% 41% 35% 45% 38% 52% 40% 33% 36% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0709142
GSM549102patient 115, normal, homogenized [OPG study]4.9678139
GSM549104patient 119, normal, homogenized [OPG study]5.8458856
GSM549108patient 138, normal, homogenized [OPG study]5.1832843
GSM549119patient 077, normal, homogenized [OPG study]4.8979238
GSM549133patient 032, cancer, homogenized [OPG study]4.9213740
GSM549139patient 042, cancer, homogenized [OPG study]4.8203137
GSM549099patient 107, normal, homogenized [OPG study]5.0641741
GSM549109patient 139, normal, homogenized [OPG study]4.9159238
GSM549110patient 046, normal, homogenized [OPG study]4.9555339
GSM549114patient 063, normal, homogenized [OPG study]4.8987539
GSM549122patient 082, normal, homogenized [OPG study]5.113342
GSM549134patient 033, cancer, homogenized [OPG study]4.7180434
GSM549136patient 036, cancer, homogenized [OPG study]4.7014835
GSM549140patient 044, cancer, homogenized [OPG study]4.7227335
GSM549111patient 047, normal, homogenized [OPG study]5.1271443
GSM549113patient 057, normal, homogenized [OPG study]4.8884239
GSM549132patient 031, cancer, homogenized [OPG study]4.9327539
GSM549137patient 038, cancer, homogenized [OPG study]4.9424139
GSM549142patient 047, cancer, homogenized [OPG study]4.7339932
GSM549100patient 110, normal, homogenized [OPG study]4.9176338
GSM549107patient 135, normal, homogenized [OPG study]4.8841438
GSM549115patient 068, normal, homogenized [OPG study]4.8971739
GSM549116patient 072, normal, homogenized [OPG study]4.9839340
GSM549120patient 078, normal, homogenized [OPG study]5.0540541
GSM549131patient 030, cancer, homogenized [OPG study]4.8546138
GSM549118patient 074, normal, homogenized [OPG study]4.9661240
GSM549129patient 027, cancer, homogenized [OPG study]4.9615739
GSM549123patient 088, normal, homogenized [OPG study]5.0194641
GSM549124patient 006, cancer, homogenized [OPG study]4.8290936
GSM549126patient 015, cancer, homogenized [OPG study]4.8088136
GSM549128patient 025, cancer, homogenized [OPG study]4.7612535
GSM549103patient 117, normal, homogenized [OPG study]5.2022143
GSM549117patient 073, normal, homogenized [OPG study]5.0538142
GSM549138patient 041, cancer, homogenized [OPG study]4.8382637
GSM549141patient 045, cancer, homogenized [OPG study]4.9661241
GSM549130patient 028, cancer, homogenized [OPG study]4.7683535
GSM549101patient 111, normal, homogenized [OPG study]5.2523445
GSM549105patient 128, normal, homogenized [OPG study]4.9376138
GSM549106patient 134, normal, homogenized [OPG study]5.6012652
GSM549112patient 048, normal, homogenized [OPG study]5.0007340
GSM549125patient 011, cancer, homogenized [OPG study]4.7064433
GSM549127patient 024, cancer, homogenized [OPG study]4.8063936
GSM549135patient 035, cancer, homogenized [OPG study]4.7793137